ARZNEIMITTELABGABEVORRICHTUNG

European patent · EP4255539 · In force

Register entry

Publication number
EP4255539
Application number
EP21823557
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 1, 2021
Published
Oct 11, 2023
Granted
Nov 5, 2025
Protection ends at the latest
Nov 30, 2041
Next annual fee due
Dec 31, 2026
IPC classes
A61M 5/32 (2006.01)
A61M 5/20 (2006.01)
Priority
EP 20315473 02.12.2020
PCT application
PCT/EP2021/083839 01.12.2021
PCT publication
WO2022/117682 09.06.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 16, 2026

    Change

    Published in Swissreg on 16.09.2026

  2. Jan 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 01.01.2026

  3. Nov 5, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 05.11.2025

Parties

Holder

SANOFI

Sanofi

46 avenue de la Grande Armée, 75017 Paris, FR

Inventor

DASBACH, Uwe

65926 Frankfurt am Main, DE

DENYER, Timothy

Melbourn Hertfordshire SG8 6DP, GB

KEMP, Thomas Mark

Melbourn Hertfordshire SG8 6DP, GB

ROSIER, Chris

Melbourn Hertfordshire SG8 6DP, GB

WILSON, Robbie

Melbourn Hertfordshire SG8 6DP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.